Shotaro Nakanishi

7PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersNeonatologyCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 31, 2026
Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population.

|Dec 10, 2025
Multicenter Retrospective Analysis of Acute Scrotum in the Kyushu-Okinawa Region: Diagnostic Practices, Management Patterns, and Predictors of Testicular Salvage.

Shohei Tobu, Yuka Kakinoki, Tatsuo Konomoto

|Jun 09, 2025
Current Evidences and Future Perspectives in the Management of Metastatic Non-Clear Cell Renal Cell Carcinoma.

Shotaro Nakanishi, Junichi Inokuchi

|Feb 05, 2025
Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.

Shuhei Hara, Wataru Fukuokaya, Jun Miki

|Dec 24, 2024
MUC1 expression is associated with ST3GAL2 and negatively correlated with the androgen receptor in castration-resistant prostate cancer.

Shotaro Nakanishi, Tetsuji Suda, Kei Tanaka

|Jan 09, 2024
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan.

Pageof 2

Frequent Collaborators

3 joint publications

Junichi Inokuchi

2 joint publications

Takahiro Kimura

2 joint publications

Yuto Matsushita

2 joint publications

Makito Miyake